- Home
- MED vs AMRN Comparison
MED vs AMRN Comparison
Compare MED & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MED | AMRN |
|---|---|---|
| Founded | 1980 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.0M | 304.3M |
| IPO Year | 1996 | 1998 |
Fundamental Metrics
Financial Performance| Metric | MED | AMRN |
|---|---|---|
| Price | $12.66 | $14.50 |
| Analyst Decision | Hold | Strong Sell |
| Analyst Count | 1 | 1 |
| Target Price | $12.00 | $12.00 |
| AVG Volume (30 Days) | ★ 186.4K | 67.6K |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $934,842,000.00 | $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $9.22 | $11.27 |
| 52 Week High | $15.37 | $20.90 |
Technical Indicators
Market Signals| Indicator | MED | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 60.75 | 47.21 |
| Support Level | $10.10 | $14.34 |
| Resistance Level | $14.41 | $14.49 |
| Average True Range (ATR) | 0.48 | 0.49 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 43.11 | 32.02 |
Price Performance
Historical ComparisonAbout MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.